CVS HEALTH Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CVS HEALTH Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $402.07B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $372.81B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $357.78B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $322.47B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $292.11B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $268.71B | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | $66.89B | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | $64.81B | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | $63.43B | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | $61.65B | Feb 18, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $193.92B | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $184.77B | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $177.53B | Feb 28, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $7.90B | Feb 14, 2018 |
| FY2017 | Sep 30, 2017 | $7.13B | Feb 14, 2018 |
| FY2017 | Jun 30, 2017 | $6.94B | Feb 14, 2018 |
| FY2017 | Mar 31, 2017 | $6.58B | Feb 14, 2018 |
| FY2017 | Dec 31, 2016 | $7.61B | Feb 14, 2018 |
| FY2017 | Sep 30, 2016 | $7.49B | Feb 14, 2018 |
| FY2017 | Jun 30, 2016 | $7.02B | Feb 14, 2018 |
| FY2017 | Mar 31, 2016 | $6.74B | Feb 14, 2018 |
| FY2016 | Dec 31, 2015 | $7.30B | Feb 9, 2017 |
| FY2016 | Sep 30, 2015 | $6.66B | Feb 9, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.77B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.61B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $8.34B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $4.31B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $8.00B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $7.18B | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | $1.75B | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | $1.53B | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | $1.94B | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | $1.42B | Feb 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.66B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $8.52B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $13.74B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $7.95B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $13.31B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $13.91B | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | $3.04B | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | $2.93B | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | $3.33B | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | $2.69B | Feb 18, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.64B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $9.11B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $13.43B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $16.18B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $18.27B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $15.87B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $12.85B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $8.87B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $8.01B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $10.14B | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.83B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $2.78B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $3.03B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $2.73B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $2.52B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $2.44B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $2.46B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $2.04B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.92B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $2.22B | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.54B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $253.22B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $249.73B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $228.28B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $233.00B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $230.72B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $222.45B | Feb 16, 2021 |
| FY2019 | Jan 1, 2019 | $216.67B | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $196.46B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $95.13B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $178.16B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $177.49B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $173.09B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $156.51B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $157.62B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $161.01B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $158.28B | Feb 16, 2021 |
| FY2019 | Jan 1, 2019 | $157.95B | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $137.91B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $57.44B | Feb 28, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.21B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $75.56B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $76.46B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $71.47B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $75.08B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $69.39B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $63.86B | Feb 16, 2021 |
| FY2019 | Jan 1, 2019 | $58.40B | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $58.23B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $37.69B | Feb 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.48B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $91.27B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $91.27B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $78.15B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $79.12B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $79.55B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $79.75B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $78.68B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $38.45B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $38.25B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.20B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $62.84B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $61.60B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $56.40B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $54.91B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $49.64B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | $45.11B | Feb 16, 2021 |
| FY2019 | Jan 1, 2019 | $41.09B | Feb 18, 2020 |
| FY2019 | Dec 31, 2018 | $40.91B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $43.56B | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.45B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $8.59B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $8.20B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $12.95B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $9.41B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $7.85B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $5.68B | Feb 9, 2022 |
| FY2020 | Dec 31, 2018 | $4.06B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.70B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $3.37B | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $73.43B | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $27.00B | Feb 28, 2019 |
| FY2016 | Dec 31, 2016 | $25.70B | Feb 9, 2017 |
| FY2015 | Dec 31, 2015 | $27.50B | Feb 9, 2016 |
| FY2014 | Dec 31, 2014 | $12.30B | Feb 10, 2015 |
| FY2013 | Dec 31, 2013 | $13.40B | Feb 11, 2014 |
| FY2012 | Dec 31, 2012 | $9.10B | Feb 15, 2013 |
| FY2011 | Dec 31, 2011 | $9.30B | Feb 17, 2012 |
| FY2010 | Dec 31, 2010 | $10.06B | Feb 18, 2011 |
| FY2010 | Dec 31, 2009 | $11.18B | Feb 18, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | 5 | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | 5 | Feb 8, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.27B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 1.26B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | 1.29B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 1.30B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | 1.32B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 1.31B | Feb 9, 2022 |
| FY2020 | Dec 31, 2019 | 1.30B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 1.30B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 1.01B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 1.06B | Feb 14, 2018 |